Biopharma and Patients - Pharma Rep Focus

Embracing Personalization in Biopharma Patient Support Programs

Fierce Pharma

APRIL 18, 2023

Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48

Biopharma

Biopharma Patients

Rising Investment in Patient Support Drives a Greater Biopharma Focus on Measurement

Fierce Pharma

FEBRUARY 27, 2024

Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support. A seismic shift has occurred in the healthcare landscape.

Biopharma

Biopharma Patients Healthcare Healthcare

Biopharma’s AI revolution is about more than algorithms

Fierce Pharma

SEPTEMBER 19, 2023

With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too. Especially with the proliferation of AI in other industries and chatGPT.

Biopharma

Biopharma Healthcare Healthcare Patients

The Direct-to-Patient Platform: Transforming the Patient Journey for Better Outcomes

Fierce Pharma

OCTOBER 3, 2024

Matthew Walsh, General Manager of Biopharma at ixlayer - the leading cloud-based platform powering an end-to-end, direct-to-patient healthcare solution - sat down with Fierce at Digital Phar | Matthew Walsh, General Manager of Biopharma at Ixlayer – a cloud-based platform specialist empowering operational efficiency, patient access, and improved outcomes (..)

Patients

Patients Biopharma Management Pharma

Fierce Pharma Asia—Enhertu's encore; Akeso's showstopper; GenScript and Legend's US scrutiny

Fierce Pharma

JUNE 6, 2024

AstraZeneca and Daiichi Sankyo are looking at moving their antibody-drug conjugate Enhertu into another new breast cancer patient class. AstraZeneca and Daiichi Sankyo are looking at moving their antibody-drug conjugate Enhertu into another new breast cancer patient class. lawmakers.

Biopharma

Biopharma Pharma Patients

Here’s how biopharma can better support patients while they’re searching for care

Fierce Pharma

SEPTEMBER 27, 2024

Patients with rare or complex diseases often struggle to find specialists who meet their specific condition and individual needs. Patients with rare or complex diseases struggle to find specialists who fit their unique needs, delaying crucial care. Digital tools can help.

Biopharma

Biopharma Patients

FTC order could ease biopharma competition

European Pharmaceutical Review

SEPTEMBER 4, 2023

The biopharma company will be required to seek prior approval before acquiring related products. BIO stated that the settlement will enable the FTC to protect competition, while facilitating rare disease patients to promptly benefit from the deal’s pro-competitive advantages. Divest to invest: the new normal in biopharma?

Competition

Competition Biopharma Pharmaceutical Government

How Tech Changes to Clinical Trials Help Both Patients and Biopharma Firms

MedCity News

OCTOBER 27, 2023

Technology is transforming how clinical trials are run. A panel during MedCity News’ INVEST Digital Health conference discussed the tech trends shaping the design and execution of drug studies.

Biopharma

Biopharma Patients Pharma

Lilly completes biopharma acquisitions

European Pharmaceutical Review

AUGUST 14, 2023

The goal of such therapies is to free patients from constant disease management by sensing blood glucose levels, restoring insulin production and releasing it over the long term. “By The post Lilly completes biopharma acquisitions appeared first on European Pharmaceutical Review. Both companies have been working together since 2018.

Biopharma

Biopharma Leads Medicine Management

EU pharmaceutical legislation revisions: what are the implications for biopharma?

European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The second is an adjustment of unmet need categorisation required for RDP extension; unmet need definition now encompasses ‘meaningful’ impact patient outcomes (notably including quality of life).

Biopharma

Biopharma Pharmaceutical Medicine Manufacturing

Elevating patient care from the home

MedCity News

JULY 20, 2022

By adding adherence and connectivity capabilities to home-based solutions, clinicians can maintain open lines of communication with patients, helping patients better care for themselves from the comfort of their homes.

Patients

Patients Biopharma

Divest to invest: the new normal in biopharma?

European Pharmaceutical Review

AUGUST 24, 2023

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. The post Divest to invest: the new normal in biopharma?

Biopharma

Biopharma Pharmaceutical Pharma Medical

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

Pharmaceutical Commerce

JUNE 17, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution

Distribution Biopharma Pharma Patients

Pharma Pulse 8/8/24: Addressing Maternal Health Disparities and Driving Change, Abacavir Increases Cardiovascular Risk in Patients With HIV & more

Pharmaceutical Commerce

AUGUST 8, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution

Distribution Biopharma Marketing Pharma

Allying With Patients to Make Every Cure Possible

MedCity News

MAY 22, 2024

To win the battle against rare diseases, drug developers must work hand-in-hand with patients. The post Allying With Patients to Make Every Cure Possible appeared first on MedCity News.

Patients

Patients Biopharma

Fierce Pharma Asia—Takeda restructures; Lilly, Innovent tout GLP-1 win; BIO warns of decoupling damage

Fierce Pharma

MAY 9, 2024

A BIO survey of biopharma companies indicated that a sudden break-off from Chinese CDMOs could harm millions of patients. Innovent Biologics' GLP-1R/GCGR dual agonist, licensed from Eli Lilly, has notched a second positive phase 3 rea | Takeda launched a restructuring to achieve “organizational simplicity.” And more.

Biopharma

Biopharma Pharma Patients

Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose

MedCity News

NOVEMBER 22, 2024

A patient death in a clinical trial usually prompts the FDA to impose a clinical hold. The post Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose appeared first on MedCity News.

FDA

FDA Patients Biopharma Pharma

An Attack on Patients’ Right to Informed Consent

MedCity News

MARCH 6, 2024

This case, about the claim that Merck failed to warn patients about the risk of typical femoral fracture, reaches past this suit to potentially change pharmaceutical companies’ relationship with the FDA.

Patients

Patients FDA Pharmaceutical Biopharma

FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery

MedCity News

APRIL 23, 2024

ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The post FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery appeared first on MedCity News. The novel immunotherapy works by sparking activity from three types of immune cells.

FDA

FDA Patients Biopharma Pharma

With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs

MedCity News

SEPTEMBER 4, 2024

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players.

Patients

Patients Medical Pharmaceutical Biopharma

Telehealth Can Broaden Reach of Palliative Care for Lung Cancer Patients, Per MGH Study

MedCity News

JUNE 16, 2024

Investigators say these results indicate telehealth can make palliative care accessible to more cancer patients. The post Telehealth Can Broaden Reach of Palliative Care for Lung Cancer Patients, Per MGH Study appeared first on MedCity News.

Patients

Patients Biopharma

The PharmaVoice 100: Rare disease warriors

PharmaVoice

OCTOBER 16, 2023

Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.

Biopharma

Biopharma Patients

How Patient Monitoring Is Poised to Revolutionize Healthcare

MedCity News

FEBRUARY 26, 2023

Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.

Healthcare

Healthcare Healthcare Patients Biopharma

What the Radiopharmaceutical Pipeline Means for Patient Care

MedCity News

OCTOBER 16, 2023

With increased access to cutting-edge imaging, improved treatment options, greater personalization of treatment, reduced radiation exposure, and potential for future advances, patients can expect to receive more advanced medical care tailored to their specific needs through radiopharmaceuticals.

Patients

Patients Medical Biopharma

New mass spectrometry Chapter could “revolutionise” biopharma quality assurance

European Pharmaceutical Review

DECEMBER 2, 2024

The recognition of mass spectrometry as a complementary method opens the door for us to support biopharmaceutical developers in getting their drugs approved for clinical trials and patient treatment,” Mørtz continued.

Biopharma

Biopharma Manufacturing Consulting Safety

$1.7b acquisition to develop rare haematology therapy

European Pharmaceutical Review

MAY 12, 2023

Swedish Orphan Biovitrum AB (Sobi ® ) has agreed to acquire CTI BioPharma for $1.7 There is a large unmet medical need within myelofibrosis, in particular for patients suffering from thrombocytopenia who are inadequately treated by existing medicines.

Food and Drug Administration

Food and Drug Administration Biopharma Medicine Food

The Key To Faster, More Efficient Clinical Trials? Patient Centricity

MedCity News

DECEMBER 8, 2022

Added complexity to daily life is likely why patient dropout rates remain high, with 19% leaving studies before completion. Truly patient-centric trials will allow for broader participation, allowing patients to decide how and when they want to engage in a study.

Patients

Patients Biopharma

Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs

MedCity News

APRIL 8, 2024

The expanded FDA approvals makes these cell therapies more accessible to more patients, broadening the market for both products. The post Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs appeared first on MedCity News.

FDA

FDA Patients Marketing Biopharma

Patient Death Prompts FDA Hold on Tests of Drug in Atopic Dermatitis & Asthma

MedCity News

FEBRUARY 20, 2024

The FDA clinical hold follows a patient death from liver failure that may be associated with zelnecirnon, an experimental Rapt Therapeutics drug. The biotech notes that no other patient has experienced liver problems and this safety signal has not been seen in any other tests of the molecule.

FDA

FDA Patients Safety Biopharma

FDA Approves First Drug for Treating Agitation in Alzheimer’s Patients

MedCity News

MAY 11, 2023

Rexulti, a drug for schizophrenia and depression, now has an additional approval for treating agitation in Alzheimer’s disease patients. The FDA decision makes the Otsuka Pharmaceutical and Lundbeck product the first drug approved for this indication.

FDA

FDA Patients Pharmaceutical Biopharma

Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative

MedCity News

SEPTEMBER 5, 2024

Positive preliminary results for Eli Lilly’s efsitora alfa continue to build the case for this once-weekly insulin in type 2 diabetes patients. The post Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative appeared first on MedCity News.

Patients

Patients FDA Marketing Biopharma

Silver lining: Pandemic learnings propel decentralized trial approaches for patients

MedCity News

OCTOBER 27, 2022

Two decentralized clinical trial methodologies that are “low-hanging fruit” include automating data integration for patient trial selection and establishing standardized, electronic clinical trial templates and procedures.

Electronics

Electronics Patients Biopharma

The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients

MedCity News

JUNE 21, 2024

The post The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients appeared first on MedCity News. Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.

Medical

Medical Patients Biopharma Pharma

Heartburn Drug from Phathom Pharma Expands Its Approval to Cover More GERD Patients

MedCity News

JULY 18, 2024

Expanded FDA approval of Phathom Pharmaceuticals drug Voquezna now includes patients with non-erosive gastroesophageal reflux disease (GERD). The post Heartburn Drug from Phathom Pharma Expands Its Approval to Cover More GERD Patients appeared first on MedCity News. Phathom licensed its flagship product from Takeda Pharmaceutical.

Pharma

Pharma Patients FDA Pharmaceutical

Generative AI’s potential to speed delivery of improved patient outcomes

Clarivate

JUNE 29, 2023

We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.

Patients

Patients Safety Healthcare Healthcare

A sad day for us all as the FDA continues to lose credibility

World of DTC Marketing

JUNE 8, 2021

The Financial Times said , “Michael Carome, director of the health research group at Public Citizen, said, “these costs to patients, to their families, are just not justified based upon what we know about this drug”. There are no efficacy data to clearly demonstrate this drug helps patients. Nowhere to be seen.

FDA

FDA Food and Drug Administration Patients Biopharma

Alpine stops enrollment in cancer drug study after second patient death this year

MedCity News

OCTOBER 24, 2022

The patient who died in the Phase 1 test of Alpine Immune Sciences drug, davoceticept, reportedly suffered the same cardiovascular complication as the first patient. The biotech company is stopping enrollment in two clinical tests of the drug and assessing all patients in the studies.

Patients

Patients Biopharma Pharma

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

MedCity News

NOVEMBER 10, 2024

The post Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence appeared first on MedCity News.

Patients

Patients Medicine Healthcare Healthcare

Streamlining Clinical Research Through Patient Centricity: Addressing Key Challenges Impeding Administrative Operations

MedCity News

NOVEMBER 1, 2023

Investing in comprehensive patient concierge services keeps trial administrators on track by removing the burden of logistical support and improving the overall participant experience, making dropouts and trial delays much less likely.

Patients

Patients Biopharma

The patient privacy factor in clinical trials

MedCity News

SEPTEMBER 7, 2022

In the first quarter of 2022, my personal life converged with my work life concerning […].

Patients

Patients Biopharma

FDA approval of AstraZeneca drug is first for a new group of breast cancer patients

MedCity News

AUGUST 5, 2022

Enhertu, a breast cancer drug from AstraZeneca and Daiichi Sankyo, is now FDA approved for treating patients whose tumors express low levels of the protein HER2. The decision makes the infused therapy the first targeted treatment for this new category of breast cancer patients.

FDA

FDA Patients Biopharma Pharma

Novartis collaboration to innovate subcutaneous drug delivery

European Pharmaceutical Review

AUGUST 28, 2024

This platform enables high concentrations of biologics to be delivered in a single dose, improving the convenience of administration and patient and treatment compliance, according to Lindy Biosciences. Lindy Biosciences will receive an upfront payment of $20 million as part of the transaction. percent).

Biopharma

Biopharma Medicine Patients Sales

Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think

MedCity News

JULY 10, 2024

The post Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think appeared first on MedCity News. Amylyx plans to advance this GLP-1 antagonist into Phase 3 testing for post-bariatric hypoglycemia, a rare condition in which blood sugar levels drop precipitously.

Patients

Patients Pharmaceutical Marketing Biopharma

Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds

MedCity News

NOVEMBER 20, 2022

While attention is focused on the former Lilly asset, also at stake is Acrivon’s technology platform that relies on proteomics rather than genomics for identifying patients appropriate for targeted therapies.

Patients

Patients Biopharma Pharma

Embracing Personalization in Biopharma Patient Support Programs

Rising Investment in Patient Support Drives a Greater Biopharma Focus on Measurement

Trending Sources

Biopharma’s AI revolution is about more than algorithms

The Direct-to-Patient Platform: Transforming the Patient Journey for Better Outcomes

Fierce Pharma Asia—Enhertu's encore; Akeso's showstopper; GenScript and Legend's US scrutiny

Here’s how biopharma can better support patients while they’re searching for care

FTC order could ease biopharma competition

How Tech Changes to Clinical Trials Help Both Patients and Biopharma Firms

Lilly completes biopharma acquisitions

EU pharmaceutical legislation revisions: what are the implications for biopharma?

Elevating patient care from the home

Divest to invest: the new normal in biopharma?

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

Pharma Pulse 8/8/24: Addressing Maternal Health Disparities and Driving Change, Abacavir Increases Cardiovascular Risk in Patients With HIV & more

Allying With Patients to Make Every Cure Possible

Fierce Pharma Asia—Takeda restructures; Lilly, Innovent tout GLP-1 win; BIO warns of decoupling damage

Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose

An Attack on Patients’ Right to Informed Consent

FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery

With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs

Telehealth Can Broaden Reach of Palliative Care for Lung Cancer Patients, Per MGH Study

The PharmaVoice 100: Rare disease warriors

How Patient Monitoring Is Poised to Revolutionize Healthcare

What the Radiopharmaceutical Pipeline Means for Patient Care

New mass spectrometry Chapter could “revolutionise” biopharma quality assurance

$1.7b acquisition to develop rare haematology therapy

The Key To Faster, More Efficient Clinical Trials? Patient Centricity

Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs

Patient Death Prompts FDA Hold on Tests of Drug in Atopic Dermatitis & Asthma

FDA Approves First Drug for Treating Agitation in Alzheimer’s Patients

Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative

Silver lining: Pandemic learnings propel decentralized trial approaches for patients

The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients

Heartburn Drug from Phathom Pharma Expands Its Approval to Cover More GERD Patients

Generative AI’s potential to speed delivery of improved patient outcomes

A sad day for us all as the FDA continues to lose credibility

Alpine stops enrollment in cancer drug study after second patient death this year

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

Streamlining Clinical Research Through Patient Centricity: Addressing Key Challenges Impeding Administrative Operations

The patient privacy factor in clinical trials

FDA approval of AstraZeneca drug is first for a new group of breast cancer patients

Novartis collaboration to innovate subcutaneous drug delivery

Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think

Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds

Stay Connected